Dr. Wong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave
Worcester, MA 01655Phone+1 774-441-7615Fax+1 508-856-4287
Summary
- Dr. Brenda Wong is a specialist in Child Neurology based in Worcester, MA. Her extensive education includes a fellowship in Child Neurology at the Cincinnati Children's Hospital Medical Center, and graduation from the National University of Singapore FOM in 1980. Dr. Wong also has wide-ranging experience in general neurology, child neurology and neuromuscular medicine and the delivery of interdisciplinary care for Duchenne muscular dystrophy (DMD) patients with complex care needs. She has a substantial list of notable publications, many of which have been cited by other works in the field. Moreover, Dr. Wong is a certified principal investigator involved in DMD clinical trials.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Child Neurology, 1994 - 1997
- National University of Singapore FOMClass of 1980
Certifications & Licensure
- MA State Medical License 2018 - 2026
- OH State Medical License 1998 - 2019
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- National Board of Physicians and Surgeons Neurology with Special Qualification in Child Neurology
Clinical Trials
- Flu Vaccine Study in Neuromuscular Patients 2011 Start of enrollment: 2011 Aug 01
- A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects Start of enrollment: 2013 May 01
- A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Appendicular lean mass index and motor function in ambulatory patients with Duchenne muscular dystrophy.Michael Kiefer, Elise Townsend, Celina Goncalves, K Courtney Shellenbarger, Perman Gochyyev
Muscle & Nerve. 2024-08-01 - 3 citationsThe Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.Francesco Muntoni, Barry J Byrne, Hugh J McMillan, Monique M Ryan, Brenda L Wong
Neurology and Therapy. 2024-02-01 - 1 citationsFunctional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials.Craig M McDonald, James Signorovitch, Eugenio Mercuri, Erik H Niks, Brenda Wong
Plos One. 2024-01-01
Press Mentions
- Gene Therapy Briefs: Cure Rare Disease CEO’s Brother Died in Clinical TrialNovember 21st, 2022
- StockWatch: Investors Weigh Genome Editing After Clinical Hold, Patient DeathNovember 10th, 2022
- A New York Man Dies While Being Treated with Experimental Gene-Editing Technology CRISPRNovember 5th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: